Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Local investor Keith Harringtonearns prestigious VC fellowship
A Kansas City-area investor that was recently accepted into an esteemed venture capital fellowship in Silicon Valley hopes to leverage the program to better his hometown. Keith Harrington, managing director at the Kansas Bioscience Authority, was accepted into the Kauffman Fellows program for venture capitalists. The program aims to enhance venture capitalists’ capabilities and grow…
1 Million Cups presenters have shot at $10K
One of the Ewing Marion Kauffman Foundation’s most popular programs, 1 Million Cups, will soon be offering entrepreneurs more than its typical morning refreshments. Program leaders announced Wednesday that it’s launching the “One in a Million” competition, in which former presenters in the program could snag $10,000. Now in more than 70 cities worldwide, 1…
DivvyHQ raises $1.8M for marketing tech
Kansas City-based DivvyHQ is ready to hit the gas after its latest investment round that will more than double its team. The marketing tech firm recently closed on a $1.8 million Series A round to boost its staff headcount and marketing outreach. Investors in the round include Dallas-based venture capital firm DAN Fund, Dundee Venture…
Mental health startup Start Talking goes mobile, scores $150K in tax credits
Depression affects about one out of every 10 Americans, including at one time Start Talking founder Mark Nolte. While a rough time in his life, Nolte’s struggle with depression in 2010 eventually led him to launch a venture that’s more easily connecting people with the help they need. Lenexa-based Start Talking offers patients a psychotherapy…